AMA Update

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster shots (including FDA and CDC recommendations), COVID case spikes related to dropping temperatures, and a reminder to get your annual flu shot.

AMA CXO Todd Unger talks with the CDC's Dr. Alex Kallen, chief of the Prevention and Response Branch in the Division of Healthcare Quality Promotion, about the importance of infection prevention and control and what physicians need to know about updated guidance in this area.  

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID-19 vaccine emergency use authorization (EUA) requests from Pfizer for children ages 5-11, as well as movement on boosters for Johnson & Johnson and Moderna vaccine recipients.

AMA CXO Todd Unger discusses navigating the resurgence of COVID cases in southern Florida with Dr. Bernie Fernandez, the CEO of Baptist Health Medical Group, and Bill Ulbricht the Chief Operating and Administrative Officer for the Clinical Enterprise division of Baptist Health South Florida.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering movement on FDA's J&J and Moderna booster EUA consideration, New York's vaccine mandate, and Merck's antiviral COVID-19 treatment pill.

AMA CXO Todd Unger talks with Dr. Pratima Sharma, executive medical director of primary care at EvergreenHealth, about how her health system quickly pivoted when it became the first location in the country to identify a COVID positive patient. Dr. Sharma shares strategies for ensuring physician well-being during crisis and how changes her health system made during the pandemic will influence care...

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the booster roll out, mask studies in schools and the continued politicization of the pandemic.

AMA CXO Todd Unger talks boosters with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices. Learn what physicians need to know about the latest Pfizer booster authorization, including who is eligible, why boosters are needed and what this means for our larger efforts to fight the pandemic. 

AMA CXO Todd Unger talks with AMA's Director of Science, Medicine and Public Health, Andrea Garcia, about trending topics related to the pandemic over the past week. Also covering Pfizer's announcement regarding vaccine effectiveness in 5-11 year olds, the FDA's decision on booster shots, and a state-by-state look at swings in COVID case count.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering recently released studies from the CDC, and what the data tells us about the effectiveness of COVID vaccines.

AMA CXO Todd Unger talks with Dr. Steven Stack, commissioner of the Kentucky Department of Public Health and former AMA president, about how Kentucky is faring in its battle with COVID, including the state's recent surge in cases and challenges posed by the politicization of health care issues.

A discussion with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA, about what physicians and patients really need to know about ivermectin.

Discussion with AMA's Director of Science, Medicine & Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering booster shots, end-of-summer case numbers and trends, as well as the growing shortage of ICU beds across the U.S.

Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), a member of ACIP’s COVID-19 Vaccine Workgroup, and chair-elect of the AMA Board of Trustees, shares details from the latest ACIP meeting, including more details on the Pfizer approval, the latest vaccine safety data and the timeline for booster shots. 

Discussion with AMA's Director of Science, Medicine & Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering challenges faced by southern states in the wake of Hurricane Ida, and the U.S. returning to a daily average of more than 100,000 COVID-19 patients hospitalized.

A discussion with Dr. Paul Offit, the director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, about the importance of getting vaccinated and what physicians need to know about COVID and kids.

A discussion with LaShyra “Lash” Nolen, founding executive director of the We Got Us Empowerment Project and president of her medical school class at Harvard Medical School, about how she’s empowering Black communities to make decisions about COVID vaccines by providing accurate, culturally sensitive information in unique ways.

AMA president and family medicine specialist, Dr. Gerald Harmon, dives into the details about the FDA’s full approval of the Pfizer vaccine—and what it means for physicians and patients.  

Discussion with AMA's Director of Science, Medicine and Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering the FDA's full approval of the Pfizer COVID-19 vaccine, booster shots and vaccine mandates.

A discussion with with Jordan Tralins, a rising junior at Cornell University and founder of the COVID Campus Coalition, about her work to address vaccine hesitancy among young adults.  Follow COVID Campus Coalition on Instagram & TikTok @covid_campus_coalition or visit the website for more information: https://covidcampuscoalition.weebly.com/

Dr. Sandra Fryhofer, AMA’s liaison to ACIP and a member of ACIP’s COVID-19 Vaccine Workgroup, discusses what physicians need to know about the recent FDA authorization for a third COVID vaccine dose for immunocompromised patients.

Discussion with AMA's Director of Science, Medicine and Public Health, Andrea Garcia to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering third dose vaccines for the immunocompromised, vaccine recommendations for pregnant people, and state-level approaches for students headed back to school this fall.

Discussion with AMA's Director of Science, Medicine & Public Health, Andrea Garcia, to review COVID-19 vaccine numbers and trending topics related to the pandemic over the past week. Also covering global COVID-19 milestones, booster shots, and more detail on "younger, sicker, quicker" phrase/trend.

A discussion with Robin Gelburd, JD, president of FAIR Health in New York, about the organization’s recent study on patients with long-haul COVID in what is currently the largest study to date looking at long-term symptoms post-COVID infection.